Skip to main content
Premium Trial:

Request an Annual Quote

TruDiagnostic Receives CLIA Certification for Kentucky Laboratory

NEW YORK – TruDiagnostic said on Monday that its Lexington, Kentucky-based laboratory has received CLIA certification in 49 states.

The CLIA certification includes advanced registration in California, Maryland, Rhode Island, and Pennsylvania. TruDiagnostic said in a statement that it expects to receive final registration in New York next month. A spokesperson for the company noted that New York's Clinical Laboratory Evaluation Program required additional information beyond the federal requirements for CLIA certification.

TruDiagnostic also said it launched a new dual-facing portal interface with a focus on epigenetics and reporting test interpretations. The portal allows patients and providers to view test results, track data, and receive personalized recommendations based on individual epigenetic data.

The health data company plans to launch the second phase of the portal in the third quarter of 2021, with new features such as multiple interfaces with healthcare providers' electronic medical records, connections with wearable devices for remote health monitoring, and enhanced web-based reporting. Patients will be able to receive personalized nutrition and fitness recommendations, while providers can view interventional recommendations.

TruDiagnostic was founded in 2020 and focuses on multiomics and epigenetics, with an epigenetic database of DNA methylation markers and covariates. Its TruAge test measures a patient's biological age by looking at DNA methylation, according to the company's website.

The Scan

Renewed Gain-of-Function Worries

The New York Times writes that the pandemic is renewing concerns about gain-of-function research.

Who's Getting the Patents?

A trio of researchers has analyzed gender trends in biomedical patents issued between 1976 and 2010 in the US, New Scientist reports.

Other Uses

CBS Sunday Morning looks at how mRNA vaccine technology could be applied beyond SARS-CoV-2.

PLOS Papers Present Analysis of Cervicovaginal Microbiome, Glycosylation in Model Archaea, More

In PLOS this week: functional potential of the cervicovaginal microbiome, glycosylation patterns in model archaea, and more.